Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 1467 entries
View as:

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata

Phase: N/A Priority: Normal
NCT ID: NCT06444451 Org: User:
Start: 06/06/24 End: 01/05/28 Due: 01/05/29

An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis

Phase: N/A Priority: Normal
NCT ID: NCT01920893 Org: User:
Start: 08/31/13 End: 11/30/14 Due: 11/30/15

A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00637884 Org: User:
Start: 11/30/03 End: 02/29/04 Due: 02/28/05

Efficacy Safety of a Combination Thiocolchicoside+Ketoprofen Compared to Thiocolchicoside Twice a Day for 7 Days in Patients Suffering From Acute Non Specific Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT00679146 Org: User:
Start: 04/30/08 End: 06/30/09 Due: 06/30/10

Dermacyd Silver Frutal (Lactic Acid) - Photo Evaluation.

Phase: N/A Priority: Normal
NCT ID: NCT00933075 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10

Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00687765 Org: User:
Start: 07/31/08 End: 06/30/15 Due: 06/30/16

Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05429762 Org: User:
Start: 10/03/22 End: 04/10/24 Due: 04/10/25

Insulin Glargine in Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00311818 Org: User:
Start: 06/30/03 End: - Due: -

A Phase 1/Phase 2 Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With Phenylketonuria

Phase: N/A Priority: Normal
NCT ID: NCT05972629 Org: User:
Start: 08/07/23 End: 04/01/31 Due: 04/01/32

Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control

Phase: N/A Priority: Normal
NCT ID: NCT00283049 Org: User:
Start: 02/28/06 End: 11/30/08 Due: 11/30/09

A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With Depression

Phase: N/A Priority: Normal
NCT ID: NCT00250653 Org: User:
Start: 05/31/05 End: 04/30/07 Due: 04/30/08

Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00471965 Org: User:
Start: 03/31/07 End: 03/31/10 Due: 03/31/11

To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent

Phase: N/A Priority: Normal
NCT ID: NCT00620100 Org: User:
Start: 09/30/04 End: 04/30/05 Due: 04/30/06

SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT00071279 Org: User:
Start: 11/30/03 End: 12/31/05 Due: 12/31/06

Goal Attainment and Physical Activity in People With Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT06530030 Org: User:
Start: 11/26/24 End: 08/31/26 Due: 08/31/27

A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen

Phase: N/A Priority: Normal
NCT ID: NCT04845958 Org: User:
Start: 06/30/21 End: 09/24/25 Due: 09/24/26

PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone

Phase: N/A Priority: Normal
NCT ID: NCT00291005 Org: User:
Start: 08/31/04 End: - Due: -

Satavaptan Dose-Ranging Study in the Prevention of Ascites

Phase: N/A Priority: Normal
NCT ID: NCT00501384 Org: User:
Start: 04/30/04 End: 05/31/05 Due: 05/31/06

Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors

Phase: N/A Priority: Normal
NCT ID: NCT00458081 Org: User:
Start: 03/31/07 End: 01/31/09 Due: 01/31/10

Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Photo Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT00783666 Org: User:
Start: 08/31/08 End: 09/30/08 Due: 09/30/09

Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions

Phase: N/A Priority: Normal
NCT ID: NCT00350038 Org: User:
Start: 02/28/05 End: 08/31/07 Due: 08/31/08

Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT03996291 Org: User:
Start: 09/23/19 End: 11/26/24 Due: 11/26/25

Implementation and Evaluation of a Rare Disease Algorithm to Identify Persons at Risk of Gaucher Disease Using Data From Electronic Health Records (EHRs) in the United States (Project Searchlight)

Phase: N/A Priority: Normal
NCT ID: NCT05908656 Org: User:
Start: 04/02/24 End: 08/26/24 Due: 08/26/25

APIDRA Registration Study

Phase: N/A Priority: Normal
NCT ID: NCT00489190 Org: User:
Start: 08/31/05 End: - Due: -

Hydroxychloroquine in Outpatient Adults With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04333654 Org: User:
Start: 04/12/20 End: 05/26/20 Due: 05/26/21